Transcatheter arterial infusion chemotherapy with cisplatin–lipiodol suspension in patients with hepatocellular carcinoma

被引:2
作者
Masafumi Ikeda
Seishi Maeda
Hiroshi Ashihara
Hiroyasu Nagahama
Motohiko Tanaka
Yutaka Sasaki
机构
[1] Kumamoto University,Department of Gastroenterology and Hepatology, Graduate School of Medical Sciences
[2] National Cancer Center Hospital East,Division of Hepatobiliary and Pancreatic Oncology
[3] Tamana Regional Health Medical Center,Department of Gastroenterology and Hepatology
来源
Journal of Gastroenterology | 2010年 / 45卷
关键词
Hepatocellular carcinoma; Transcatheter arterial infusion chemotherapy; Cisplatin; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:60 / 67
页数:7
相关论文
共 154 条
[1]  
Llovet JM(2003)Hepatocellular carcinoma Lancet 362 1907-1917
[2]  
Burroughs A(2002)Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials Radiology 224 47-54
[3]  
Bruix J(2003)Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 429-442
[4]  
Cammà C(1988)Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma—a randomized controlled trial Gastroenterology 94 453-456
[5]  
Schepis F(1990)A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma J Hepatol 11 181-184
[6]  
Orlando A(1995)A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma N Engl J Med 332 1256-61
[7]  
Albanese M(1998)Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial J Hepatol 29 129-134
[8]  
Shahied L(1998)Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized controlled trial in a single institution Hepatology 27 1578-1583
[9]  
Trevisani F(2002)Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 1164-1171
[10]  
Llovet JM(2002)Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 1734-1739